TLC-1180

N/A

Report date: 2026/02/05 20:00:17
NME

Base Information

Drug NameTLC-1180
Drug Alias NameTLC-1180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial oxidative phosphorylation inhibitors
TargetsUpdating
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrsoBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrsoBio Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A